Comparative Safety of Two Recombinant Hepatitis B Vaccines in Children: Data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)
- 30 June 1998
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 51 (6) , 503-510
- https://doi.org/10.1016/s0895-4356(98)00014-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studiesThe Pediatric Infectious Disease Journal, 1993
- Frequency of adverse reactions to hepatitis B vaccine in 43,618 personsThe American Journal of Medicine, 1992
- The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothersThe Pediatric Infectious Disease Journal, 1991
- Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccineVaccine, 1990
- Summary of safety and efficacy data on a yeast-derived hepatitis B vaccineThe American Journal of Medicine, 1989
- Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothersJAMA, 1989
- Clinical experience with hepatitis B vaccinesAmerican Journal of Infection Control, 1989
- Overview of clinical studies with hepatitis B vaccine made by recombinant DNAJournal of Infection, 1986
- Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothersJournal of Infection, 1986
- Summary of worldwide clinical experience with H-B-Vax® (B, MSD)Journal of Infection, 1983